作者: Anuja Gupta , Gaurav Kapoor , Bharat Dalvi
关键词:
摘要: Transcatheter closure of atrial septal defects has evolved significantly over the last 20 years. replaced surgical for treatment most secundum defectsat current time. A major reason this is lower morbidity transcatheter procedures. Several devices have come into clinical use. The Amplatzer® occluder (AGA Medical Co.) currently largest reported experience and subsequently best-established safety efficacy features. Clinically challenging situations, such as larger defects, with deficient rims multiple are increasingly being addressed using approach, improved results. incidence complications reduced time, serious side effects relatively uncommon. In review, literature summarized regarding role closure, evolution different a...